IN THIS ISSUE

Thomas Reinke
The TNF inhibitors have ruled the roost, and Humira is the top selling drug in the world. But the interleukin inhibitors are challenging TNF inhibitor hegemony.
Richard Mark Kirkner
The closing of Hahnemann Hospital in Philadelphia leads to a legal battle over whether these positions can be bought and sold.
By Michael D. Dalzell
A new report finds that successful programs have a third dimension beyond financial incentives and quality measurement.

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report